Jasper Therapeutics, Inc., also known as JSPR, is a company that specializes in the field of biotechnology. As such, it is essential to analyze the technical indicators of its stock to make informed investment decisions. Technical analysis involves the study of past price and volume patterns to predict future price movements. By examining various indicators, investors can gain insight into the stock's potential strength and direction.

One commonly used technical indicator is the Relative Strength Index (RSI). The RSI measures the velocity and magnitude of the stock's price movements. A high RSI indicates overbought conditions, while a low RSI suggests oversold conditions. By interpreting the RSI, investors can determine whether the stock is likely to experience a price reversal or continue its current trend.

Jasper Therapeutics (JSPR) Technical Analysis

Technical analysis indicators for Jasper Therapeutics, Inc. (JSPR) stock including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Learn about the company's stock performance and trends without using any call to actions.

Jasper Therapeutics, Inc. (JSPR) Technical Analysis: RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.

Jasper Therapeutics

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	47.38	Neutral	374.2%
auto_graphMACD	-0.86	Neutral	-42.7%
auto_graphCCI	-34.17	Neutral	64.8%
auto_graphADX	9.12	Neutral	-
auto_graphATR	2.67	Buy	-
auto_graphWILLR	-72.20	Neutral	87.9%
auto_graphROC	-34.84	Neutral	-34.2%
auto_graphSTOCHRSI	100.00	Sell	97.9%

Buy	1	-87.50%
Hold	6	-25.00%
Sell	1	-87.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Jasper Therapeutics (JSPR) Technical Analysis

Keep an eye on Jasper Therapeutics

Frequently Asked Questions

What are the technical signals for Jasper Therapeutics (JSPR) stock based on the last 30 days?

Take Your Investments to a Whole New Level